Satoshi Sohda

Satoshi Sohda

Auto-generated profile, based on publicly available information

Satoshi Sohda

Department of Obstetrics and Gynecology, Graduate School of Medical Science, University of Tsukuba, Tsukuba 305-8577, Japan

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2003 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
SOS Okuno
S Okuno
HSH Sato
H Sato
KKK Kuriyama-Matsumura
K Kuriyama-Matsumura
MTM Tamba
M Tamba
HWH Wang
H Wang
SBS Bannai
S Bannai
Transport system xc− is a member of plasma membrane heterodimeric amino-acid transporters and consists of two protein components, xCT and 4F2hc. This system mediates cystine entry coupled with the exodus of intracellular glutamate and regulates the intracellular glutathione (GSH) levels in most mammalian cultured cells. We studied the activity of system xc− and GSH content in human ovarian cancer cell line (A2780) and its cisplatin (CDDP)-resistant variant (A2780DDP). The rate of cystine uptake was approximately 4.5-fold higher in A2780DDP cells than in A2780 cells and the cystine uptake in A2780DDP cells was mediated by system xc−. Intracellular GSH content was much higher in A2780DDP cells but it fell drastically in the presence of excess glutamate, which inhibited the cystine uptake competitively. xCT and 4F2hc mRNAs were definitely expressed in A2780DDP cells, but far less in A2780 cells. Expression of system xc− activity by transfection with cDNAs for xCT and 4F2hc made A2780 cells more resistant to CDDP. Similar results on the cystine uptake were obtained in human colonic cancer cell lines. These findings suggest that the system xc− plays an important role in maintaining the higher levels of GSH and consequently in CDDP resistance in cancer cell lines.

1 June 1997 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
SSS Sohda
S Sohda
TAT Arinami
T Arinami
HHH Hamada
H Hamada
NYN Yamada
N Yamada
HHH Hamaguchi
H Hamaguchi
TKT Kubo
T Kubo
A common missense mutation in the methylenetetrahydrofolate reductase (MTHFR) gene, a C to T substitution at nucleotide 677, is responsible for reduced MTHFR activity and associated with modestly increased plasma homocysteine concentrations. Since underlying maternal vascular disease increases the risk of pre-eclampsia, we had the working hypothesis that pre-eclampsia patients would have an increased T677 allele frequency compared with controls. The MTHFR genotypes were determined in 67 pre-eclampsia patients, 98 normal pregnant women, and 260 healthy adults by the PCR/RFLP method. The T677 allele and the genotype homozygous for the T677 allele were significantly increased in the pre-eclamptic group compared with the controls (p < 0.02 and p < 0.004, respectively). The data indicate that the T677 variant of the MTHFR gene is one of the genetic risk factors for pre-eclampsia.

29 January 2004 in Proteomics
Verified
Journal Article
Closed access
PDF file
HWHideki Watanabe
Hideki Watanabe
HHHiromi Hamada
Hiromi Hamada
NYNaoki Yamada
Naoki Yamada
SSSatoshi Sohda
Satoshi Sohda
KYKimiko Yamakawa‐Kobayashi
Kimiko Yamakawa‐Kobayashi
TATadao Arinami
Tadao Arinami

1 June 2001 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
YTYumiko O. Tanaka
Yumiko O. Tanaka
SSSatoshi Sohda
Satoshi Sohda
SSSadahiko Shigemitsu
Sadahiko Shigemitsu
MNMamoru Niitsu
Mamoru Niitsu
YIYuji Itai
Yuji Itai

1 May 2000 in Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
NYNaoki Yamada
Naoki Yamada
TATadao Arinami
Tadao Arinami
KYKimiko Yamakawa-Kobayashi
Kimiko Yamakawa-Kobayashi
HWHideki Watanabe
Hideki Watanabe
SSSatoshi Sohda
Satoshi Sohda
HHHideo Hamaguchi
Hideo Hamaguchi
Preeclampsia is associated with thrombosis of the intervillous or spiral artery. A deletion/insertion polymorphism (4G or 5G) in the promoter of the plasminogen activator inhibitor type 1 (PAI-1) gene is suggested to be involved in regulating the synthesis of the inhibitor, 4G allele, being associated with the enhanced gene expression and plasma PAI-1 levels. We assessed the association between preeclampsia and the 4G/5G polymorphism of the PAI-1 gene in 115 preeclamptic patients, 210 pregnant controls, and 298 healthy volunteer controls. The frequency of the homozygotes for the 4G allele was significantly higher in the patients than in the control pregnant women (P = 0.04) or in the healthy volunteers (P = 0.02). The 4G allele frequency was also significantly higher in the patients than in the control group of pregnant women (P = 0.03) and in the healthy volunteers (P = 0.02). These results suggest that the presence of the 4G/4G genotype of the PAI-1 gene is one of the risk factors for preeclampsia.

27 November 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SSSatoshi Sohda
Satoshi Sohda
KSKenta Suzuki
Kenta Suzuki
IIIchiro Igari
Ichiro Igari
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet